Key result
Thrombectomy resolves early bioprosthetic valve thrombosis in acute HF, maintaining normal gradients for 3 years.
Case Report (n=1)
No
Bioprosthetic valve thrombosis should be considered as a potential cause of bioprosthetic malfunction and can present as acute heart failure, which may require surgical thrombectomy in severe cases.
Answers are grounded in this paper and cite their sources.
Thrombectomy may resolve acute failure from early bioprosthetic valve thrombosis; single case leaves open need for prospective trials before wider use.
BACKGROUND: Bioprosthetic valve thrombosis is previously considered as an extremely rare complication which hasn't been systemically recognized and understood. CASE PRESENTATION: Herein, we present an unusual case of a patient manifesting with acute heart failure, secondary to thrombus formation in a porcine aortic bioprosthesis which was implanted 11 months prior to hospitalization. Due to the patient's poor heart function and intraoperative findings, thrombectomy was performed. For our best knowledge, cases of early bioprosthetic valve thrombosis presenting with acute heart failure have seldomly been reported. CONCLUSION: Our study reviews predisposing factors, typical echocardiographic features and treatment for bioprosthetic valve thrombosis and it should be considered as a reason for bioprosthetic malfunction. A combination of clinical and echocardiographic features can help for diagnosis preoperatively. In some certain circumstances, early reoperation can be avoided if anticoagulant therapy works.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2017) conducted a case report in Bioprosthetic valve thrombosis (n=1). Thrombectomy was evaluated on Clinical recovery and transvalvular gradient. Thrombectomy successfully treated early bioprosthetic valve thrombosis presenting with acute heart failure, maintaining normal transvalvular gradients over 3 years of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: